ArticleMicrobial genomics2026
Decoding the interconnected splicing patterns of hepatitis B virus and host using large language and deep learning models.
Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Innate immune recognition and evasion strategies of hepatitis B virus: from DNA to RNA and viral proteins.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis B virus (HBV) infection causes one million deaths annually and remains a major driver of hepatocellular carcinoma. Despite its compact 3.2 kb genome, HBV exhibits extensive alternative splicing. HBV splice variants contribute to immune evasion and reduce the likelihood of achieving a functional cure. Here, we show that HBV splicing efficiency - quantified from 279 RNA-sequencing libraries of HBV-associated liver biopsies and cultured cells - correlates more strongly with disease progression than the overall proportion of spliced HBV RNA, the latter of which has been proposed as an emerging biomarker. All HBV splice sites are embedded within protein-coding regions, forming a gene structure distinct from typical host splice sites. To decode the sequence determinants of HBV splicing, we apply SpliceBERT and OpenSpliceAI to 4,706 HBV genomes. These models reveal that HBV splice donor sites share features with host splice donor sites, whereas HBV splice acceptor sites are more cryptic. These patterns likely reflect constraints imposed by HBV's compact genome, which must accommodate overlapping protein-coding regions. Motif conservation and splicing propensity analyses across HBV genomes reveal context- and genotype-specific splicing patterns, indicating regulation by sequence context. HBV genotypes may have coevolved with their human hosts to exploit suboptimal but spliceable host-like motifs without disrupting their gene structure, supporting mechanisms of viral persistence and immune evasion. This study demonstrates the utility of artificial intelligence in decoding viral splicing patterns and provides a framework for investigating co-transcriptional processes in other clinically important viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.